Short description:
Monoclonal Antibody
Drug notes:
Also Clin3 thyroid eye disease, Clin2b inflammatory demyelinating polyneuropathy, Clin2 Graves disease; IMVT-1402 Clin0 autoimmune diseases
Long description:
Immunovant is creating therapies for autoimmune diseases. Autoimmune diseases arise when a patient's immune system incorrectly identifies healthy cells as harmful and thus generates autoantibodies. FcRn is a protein receptor that prevents degradation of autoantibodies. Immunovant’s lead product, IMVT-1401, is a human anti-FcRn monoclonal antibody that can be delivered via subcutaneous injection. IMVT-1401 inhibits and enhances degradation of FcRn, thereby allowing degradation of autoantibodies that cause autoimmune disease. Immunovant plans to test IMVT-1401 against a variety of indications, including thyroid eye disease and Myasthenia Gravis.
Jobs:
Senior Medical Director, Medical Affairs (Rheumato... Remote|1 day ago
Senior Manager, Statistical Programming Remote|2 days ago
Manager, Clinical Supply Chain Tech Operations Remote|4 days ago
Vice President, Clinical Operations Remote|5 days ago
Associate Director, Statistical Programming Remote|9 days ago
Associate Director, CMC Upstream Process Developme... Remote|10 days ago
Director, Program Management Remote|10 days ago
Associate Director, Drug Product Technology Remote|11 days ago
Associate Director/Director, Biostatistics Remote|30 days ago
Director, Regulatory Affairs Strategy Remote|36 days ago
Associate Director, R&D Accounting Remote|36 days ago
Medical Affairs Writer Remote|36 days ago
Director, Clinical Pharmacology Remote|38 days ago
Senior Analyst, Financial Planning & Analysis Remote|46 days ago
Senior Accountant Remote|51 days ago
Senior Director IT Operations & G&A Systems Remote|52 days ago
Senior Director R&D IT Remote|57 days ago
Senior Director, Clinical Quality Assurance (CQA) Remote|65 days ago
Director, Clinical Procurement & Supplier Manageme... Remote|100+ days ago
Senior Director, Clinical Operations Remote|100+ days ago